Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADJUVITE trial of adalimumab for uveitis associated with juvenile idiopathic arthritis
2010-019441-26Phase 2
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of adalimumab in uveitis and juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Ocular inflammation reduction.
02
Drugs
03
Conditions
uveitisjuvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2010-019441-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019441-26.